| Nick Lane nick.lane@ucl.ac.uk |
|||||
|
PUBLICATIONS Books 1. Lane, Nick. Life Ascending: The Ten Great Inventions of Evolution. WW Norton/Profile, 2009 2. Lane, Nick. Power, Sex, Suicide: Mitochondria and the Meaning of Life. OUP, Oxford, 2005 3. Fuller BJ, Lane N, Benson EE, (Eds.) Life in the Frozen State. CRC Press, Boca Raton, 2004 4. Lane, Nick. Oxygen: The Molecule that made the World. OUP, Oxford, 2002
Articles 1. Lane N. Genomic matching and the evolution of eukaryote ageing. In preparation. 2. Lane N, Martin W. The energetics of genome complexity. Nature, in press; 2010. 3. Lane N. Why are cells powered by proton gradients? Nature Education, in press; 2010. 4. Lane N. Chance or necessity? Bioenergetics and the probability of life. J Cosmology 10: 7; 2010. 5. Lane N. Genesis revisited. New Scientist, 7 August: 36-39; 2010 6. Lane N. Intelligent non-design and the origins of life. J Cosmology 8: 16; 2010. 8. Lane N. Life's a gas. New Scientist, 6 February: 36-39; 2010. 9. Lane N. On the origin of barcodes. Nature 462: 272-274; 2009. 10. Lane N. Cradle of life. New Scientist, October 17: 38-42; 2009. 11. Lane N. Why sex is worth losing your head for. New Scientist 13 June: 40-43; 2009. 12. Lane N. The furnace within. New Scientist 07 February: 42-45; 2009. 14. Lane N. One baby, two mums. New Scientist, 7 June: 38-41; 2008. 15. Lane N. Origins of Death. Nature 453: 583-585; 2008. 17. Lane N. What's in the rising tide? Nature 449: 778-780; 2007. 18. Lane N. Reading the book of death. Nature 448: 122-125; 2007. 19. Lane N. Power games. Nature, 443: 901-903; 2006. 20. Lane N. What can’t bacteria do? Nature, 441: 274-7; 2006. 21. Lane N. Powerhouse of disease. Nature, 440: 600-2; 2006. 22. Lane N. Plugging the mitochondrial leak. The Scientist, 20: 34; 2006. 24. Lane NJ. New light on medicine. Scientific American, January 2003 25. Lane NJ. Born to the purple: the story of porphyria. Scientific American online, December 2002 26. Lane NJ. The Big O. New Scientist, December 14, 2002 27. Lane NJ. Medical constraints on the quantum mind. Review article. J Roy Soc Med 93: 571-575; 2000 28. Lane NJ. Blood ties. The Sciences. New York Academy of Sciences. Sept/Oct pp 24-29, 1998; discussion Jan/Feb 1999 31. Lane, NJ. Thrombolytic therapy for acute ischaemic stroke. Letter. Lancet 350: 1475-1476; 1997 32. Lane NJ. Radical Problems in Renal Transplantation. Biologist 1996; 43: 110-113 33. Lane NJ, Thorniley MS, Manek S, Fuller BJ, Green CJ. The effect of mannitol and polyethylene glycol on the action of frusemide during renal storage and transplantation. Transplantation 62: 575-582; 1996 34. Lane NJ, Thorniley MS, Manek S, Fuller BJ, Green CJ. Hemoglobin oxygenation kinetics and secondary ischemia in renal transplantation. Transplantation 61: 689-696; 1996 35. Lane NJ, Thorniley MS, Manek S, Fuller BJ, Green CJ. Iron chelation, respiratory chain function and tubular necrosis in renal transplantation. Biochem Soc Trans 23: 524S; 1995. 36. Lane NJ, Thorniley MS, Manek S, Fuller BJ, Green CJ. Iron chelation and respiratory chain function in vivo in renal ischaemia-reperfusion injury. Abstract. Clin Sci 89: 31P; 1995 37. Lane NJ, Thorniley MS, Manek S, Fuller BJ, Green CJ. Inhibition of leukotriene B4 synthesis does not prevent development of acute renal failure following storage and transplantation. Transplantation 58: 1303-1308; 1994 38. Lane NJ, Thorniley MS, Manek S, Green CJ. Vascular congestion does not correlate with mitochondrial dysfunction following renal transplantation. J Pathol 172 (suppl): 138A; 1994 40. Thorniley MS, Lane NJ, Manek S, Green CJ. Non-invasive monitoring of renal haemoglobin oxygenation kinetics following hypothermic storage and transplantation. Biochem Soc Trans 21: 501S; 1993 41. Thorniley MS, Lane NJ, Green CJ. Non-invasive monitoring of renal tissue oxygen sufficiency for transplantation. Clin Sci 85: 22P; 1993 42. Thorniley MS, Lane NJ, Manek S, Green CJ. In vivo monitoring of respiratory chain dysfunction following renal storage and transplantation. Biochem Soc Trans 21: 500S; 1993 43. Gower JD, Lane NJ, Goddard JG, Manek S, Ambrose IJ, Green CJ. Ebselen: Antioxidant capacity in renal preservation. Biochem Pharmacol 43: 2341-2348; 1992 44. Toffa SEK, Fuller BJ, Gower JD, Lane NJ, Green CJ. Oxygen-free reperfusion of ischaemic kidneys. Int J Rad Biol 62: 116; 1992
Book chapters 1. Lane N. The evolution of oxidative stress. In: Principles of Free Radical Biomedicine. Eds. Pantopoulos K, Schipper H. Nova Science Publications Inc, Hauppauge, NY, 2011. 3. Lane N. The future of Cryobiology. In: Life in the Frozen State, Eds: Fuller B, Lane NJ, Benson EE. Taylor and Francis, London, 2004. 4. Thorniley MS, Lane NJ, Simpkin S, Fuller BJ, Jenabzadeh MZ, Green CJ. Monitoring of mitochondrial NADH levels by surface fluorometry as an indication of ischaemia during hepatic and renal transplantation. In Oxygen Transport to Tissue Vol XVII (Eds Ince C, Kesecioglu J, Trelci I, Apkir K); Plenum Press, New York, 1996, pp 431-444.
Features for EuroTimes (European Society for Cataract and Refractive Surgeons) 1. Lane N. Darwin and the evolution of the eye. EuroTimes (ESCRS) June 2009. 2. Lane N. MRSA: The rising menace. EuroTimes (ESCRS) October 2008. 3. Lane N. Who is paying the piper? Open access journals. EuroTimes (ESCRS) January 2008. 4. Lane N. Beyond the IOL. EuroTimes (ESCRS) September 2007. 5. Lane N. To block or not to block: Is blue light the enemy? EuroTimes (ESCRS) July 2007. 6. Lane N. Cannabis and glaucoma - the inside story. EuroTimes (ESCRS) April 2007. 7. Lane N. The great accomodation debate. EuroTimes (ESCRS) January 2007. 8. Lane N. Mitochondria – alpha and omega of retinal disease? EuroTimes (ESCRS) September 2006. 10. Lane N. New VEGF antagonists in AMD: new quandaries abound. EuroTimes (ESCRS) November 2005. 11. Lane N. Stem cells in ophthalmology: dawn of a new era? EuroTimes (ESCRS) October 2005. 12. Lane N. Ophthalmic gene testing: ready for prime time? EuroTimes (ESCRS) August 2005. 15. Lane N. Rheopheresis: ready for prime time? EuroTimes (ESCRS) November 2004. 16. Lane N. Vision 2020: Eliminating preventable blindness in the developing world? EuroTimes (ESCRS) February 2004. 17. Lane N. EMEA on the brink of the new EU. EuroTimes (ESCRS) November 2003. 18. Lane N. Antioxidants: who do you believe? EuroTimes (ESCRS) October 2003. 19. Lane N. Verteporfin’s efficacy in AMD comes into focus. EuroTimes (ESCRS) August 2003. |
|||||